2hOpinion
Intel appoints Lip-Bu Tan as CEO, continuing Gelsinger's foundry strategy, which I believe is doomed to fail and a red flag ...
Molecure achieved key milestones in the development of its innovative therapies in 2024 and plans to accelerate research and ...
Tuspetinib Triple Drug Frontline Therapy Advancing in TUSCANY Clinical Trial Results to Date Highlight TUS Potential as an ...
Legend Holdings Delivered Significant Recovery in 2024 PerformanceHONG KONG, Mar 28, 2025 - (ACN Newswire) - Legend Holdings Corporation ("Legend Holdings" or the "Company" Stock Code: 3396.HK) announ ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback